Clinical and Phantom Validation of a Deep Learning Based Denoising Algorithm for F-18-FDG PET Images from Lower Detection Counting in Comparison with the Standard Acquisition
Overview
Authors
Affiliations
Background: PET/CT image quality is directly influenced by the F-18-FDG injected activity. The higher the injected activity, the less noise in the reconstructed images but the more radioactive staff exposition. A new FDA cleared software has been introduced to obtain clinical PET images, acquired at 25% of the count statistics considering US practices. Our aim is to determine the limits of a deep learning based denoising algorithm (SubtlePET) applied to statistically reduced PET raw data from 3 different last generation PET scanners in comparison to the regular acquisition in phantom and patients, considering the European guidelines for radiotracer injection activities. Images of low and high contrasted (SBR = 2 and 5) spheres of the IEC phantom and high contrast (SBR = 5) of micro-spheres of Jaszczak phantom were acquired on 3 different PET devices. 110 patients with different pathologies were included. The data was acquired in list-mode and retrospectively reconstructed with the regular acquisition count statistic (PET100), 50% reduction in counts (PET50) and 66% reduction in counts (PET33). These count reduced images were post-processed with SubtlePET to obtain PET50 + SP and PET33 + SP images. Patient image quality was scored by 2 senior nuclear physicians. Peak-signal-to-Noise and Structural similarity metrics were computed to compare the low count images to regular acquisition (PET100).
Results: SubtlePET reliably denoised the images and maintained the SUV values in PET50 + SP. SubtlePET enhanced images (PET33 + SP) had slightly increased noise compared to PET100 and could lead to a potential loss of information in terms of lesion detectability. Regarding the patient datasets, the PET100 and PET50 + SP were qualitatively comparable. The SubtlePET algorithm was able to correctly recover the SUV values of the lesions and maintain a noise level equivalent to full-time images.
Conclusion: Based on our results, SubtlePET is adapted in clinical practice for half-time or half-dose acquisitions based on European recommended injected dose of 3 MBq/kg without diagnostic confidence loss.
Similarity and quality metrics for MR image-to-image translation.
Dohmen M, Klemens M, Baltruschat I, Truong T, Lenga M Sci Rep. 2025; 15(1):3853.
PMID: 39890963 PMC: 11785996. DOI: 10.1038/s41598-025-87358-0.
Whole-body PET image denoising for reduced acquisition time.
Kruzhilov I, Kudin S, Vetoshkin L, Sokolova E, Kokh V Front Med (Lausanne). 2024; 11:1415058.
PMID: 39403284 PMC: 11471667. DOI: 10.3389/fmed.2024.1415058.
Weyts K, Lequesne J, Johnson A, Curcio H, Parzy A, Coquan E EJNMMI Res. 2024; 14(1):72.
PMID: 39126532 PMC: 11316728. DOI: 10.1186/s13550-024-01128-z.
Dutta K, Laforest R, Luo J, Jha A, Shoghi K Med Phys. 2024; 51(6):4324-4339.
PMID: 38710222 PMC: 11423763. DOI: 10.1002/mp.17105.
Liu L, Chen X, Wan L, Zhang N, Hu R, Li W Br J Radiol. 2023; 96(1149):20230038.
PMID: 37393527 PMC: 10461288. DOI: 10.1259/bjr.20230038.